Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 886982 NEW YORK, NY
Back to LXEO Full portfolio

Position in LXEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,006,442
-$1,185,896 QoQ
Shares Held
2,149,612
+10.2% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 141 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 99% Shared 1% None 0%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. LXEO ranks #151 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in LXEO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,006,442 2,149,612
2026-03-31 $11,192,338 1,949,885
2025-12-31 $7,763,819 781,855
2025-09-30 $945,549 142,402
2025-06-30 $146,198 36,368
2025-03-31 $274,504 79,108
2024-12-31 $598,127 90,901
2024-09-30 $693,828 76,751
2024-06-30 $430,721 26,853
2024-03-31 $369,405 23,559